产品中心 / 产品类型 / 重组蛋白 / 其他蛋白

Recombinant Human Peptide Ready HLA-A*02:01&B2M Monomer Protein (RP03189)

Recombinant Human Peptide Ready HLA-A 02:01&B2M Monomer on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

The purity of Human Peptide Ready HLA-A 02:01&B2M Monomer is greater than 95% as determined by SEC-HPLC.

All(2)|
货号: RP03189
促销价:   ¥3000
货    期:在线咨询货期
抗体定制服务咨询 |
商城订购

详细信息

种属
Human
表达宿主
HEK293 cells
描述
Recombinant Human Peptide Ready HLA-A*02:01&B2M Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus. It contains Gly25-Thr305 (HLA-A*02:01) and Ile21-Met119 (B2M). [Accession | A0A140T913 (HLA-A*02:01) & P61769 (B2M)]
标签
C-His&Avi tag
纯度
> 95% by Tris-Bis PAGE and HPLC.
内毒素
< 1.0 EU/μg of the protein by LAL method.
制剂
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. Contact us for customized product form or formulation.
储存
Store the lyophilized protein at -20°C to -80 °C for 12 months.
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.未开盖的干粉蛋白在 -20°C至-80°C可保存12个月;
复溶之后,蛋白溶液在-20°C及以下可保存3个月,在2-8℃可保存1周。
复溶
Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.收到重组蛋白产品之后请检查蛋白冻干粉末是否贴于瓶底,如果粉末浮起,开盖之前请先低温离心。将蛋白用说明书中指定的缓冲液复溶至0.1-0.5 mg/mL(请注意蛋白复溶浓度不能低于0.1 mg/mL),室温平衡5-10 min保证充分溶解,复溶过程中请不要剧烈涡旋及吹打蛋白溶液。如需长期储存,建议复溶时添加载体蛋白或者稳定剂(如0.1% BSA, 5% HSA, 10% FBS 或者 5% 海藻糖),同时将复溶后的蛋白溶液按照需求进行分装,储存于-20°C至-80°C,随取随用,避免反复冻融。

蛋白复溶计算器

请在蛋白复溶计算器中输入蛋白总质量和所需终浓度,快速计算您需要添加溶液的体积吧!
=
÷

背景信息

Peptide Ready HLA-A*02:01&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-A*02:01. Peptide ready MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.

>